Literature DB >> 18448773

A prospective examination of antidepressant use and its correlates in patients with acute coronary syndrome.

Sherry L Grace1, Yvonne W Leung, Donna E Stewart.   

Abstract

BACKGROUND: Depression has been implicated in the occurrence of recurrent coronary events and cardiac or all-cause mortality in acute coronary syndrome (ACS) patients.
OBJECTIVE: The authors describe the frequency and type of antidepressant use and its correlates 18 months after ACS hospital discharge.
METHOD: A sample of 661 ACS inpatients, recruited from three hospitals, completed a sociodemographic survey and the Hospital Anxiety and Depression Scale (HADS), and clinical data were extracted from charts. A mailed survey 9 months and 18 months post-discharge assessed self-reported antidepressant use, and the HADS was re-administered.
RESULTS: Approximately 9% of participants reported antidepressant use both 9 and 18 months post-hospitalization, with 77% concordance in usage over time. Participants most frequently reported using selective serotonin reuptake inhibitors and least often tricyclics. Logistic regression revealed that antidepressant users were more likely to be anxious and have more comorbidity, and were less likely to work full-time, whereas number of medications, age, and marital status were not related.
CONCLUSION: Patients with comorbid physical and mental conditions who are unemployed may be more likely to receive an antidepressant because of greater depression symptoms or greater exposure to healthcare providers, which increases the potential for symptom recognition and treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448773      PMCID: PMC2927525          DOI: 10.1176/appi.psy.49.3.199

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  35 in total

1.  Suboptimal antidepressant use in the elderly.

Authors:  Philip S Wang; Sebastian Schneeweiss; M Alan Brookhart; Robert J Glynn; Helen Mogun; Amanda R Patrick; Jerry Avorn
Journal:  J Clin Psychopharmacol       Date:  2005-04       Impact factor: 3.153

2.  Trends in the prescribing of antidepressants following acute myocardial infarction, 1993-2002.

Authors:  Nili R Benazon; Muhammad M Mamdani; James C Coyne
Journal:  Psychosom Med       Date:  2005 Nov-Dec       Impact factor: 4.312

3.  Depression and cardiovascular disease: healing the broken-hearted.

Authors:  Mary A Whooley
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

4.  A national survey of cardiovascular physicians' beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease.

Authors:  Robert E Feinstein; Michael Blumenfield; Barbara Orlowski; William H Frishman; Simon Ovanessian
Journal:  Cardiol Rev       Date:  2006 Jul-Aug       Impact factor: 2.644

5.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

6.  Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation.

Authors:  Sherry L Grace; Susan E Abbey; Ruxandra Pinto; Zachary M Shnek; Jane Irvine; Donna E Stewart
Journal:  Psychosom Med       Date:  2005 Jan-Feb       Impact factor: 4.312

7.  Cardiovascular health and depression.

Authors:  Alexander Glassman; Peter A Shapiro; Daniel E Ford; Larry Culpepper; Mitchell S Finkel; J Robert Swenson; J Thomas Bigger; Bruce L Rollman; Thomas N Wise
Journal:  J Psychiatr Pract       Date:  2003-11       Impact factor: 1.325

8.  Cardiovascular effects of bupropion in depressed patients with heart disease.

Authors:  S P Roose; G W Dalack; A H Glassman; S Woodring; B T Walsh; E G Giardina
Journal:  Am J Psychiatry       Date:  1991-04       Impact factor: 18.112

Review 9.  Treatment of depression in patients with heart disease.

Authors:  Steven P Roose
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

Review 10.  Combined pharmacotherapy and psychological treatment for depression: a systematic review.

Authors:  Sandro Pampallona; Paola Bollini; Giuseppe Tibaldi; Bruce Kupelnick; Carmine Munizza
Journal:  Arch Gen Psychiatry       Date:  2004-07
View more
  6 in total

1.  Antidepressant Use by Class: Association with Major Adverse Cardiac Events in Patients with Coronary Artery Disease.

Authors:  Sherry L Grace; Jose R Medina-Inojosa; Randal J Thomas; Heather Krause; Kristin S Vickers-Douglas; Brian A Palmer; Francisco Lopez-Jimenez
Journal:  Psychother Psychosom       Date:  2018-03-13       Impact factor: 17.659

2.  The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients.

Authors:  Shannon Gravely-Witte; Donna E Stewart; Neville Suskin; Sherry L Grace
Journal:  J Behav Med       Date:  2009-06-06

3.  A prospective examination of patterns and correlates of exercise maintenance in coronary artery disease patients.

Authors:  Yvonne W Leung; Natalie Ceccato; Donna E Stewart; Sherry L Grace
Journal:  J Behav Med       Date:  2007-07-07

Review 4.  Prevalence of antidepressant prescription or use in patients with acute coronary syndrome: a systematic review.

Authors:  Matthew J Czarny; Erin Arthurs; Diana-Frances Coffie; Cheri Smith; Russell J Steele; Roy C Ziegelstein; Brett D Thombs
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

Review 5.  Antidepressants and cardiovascular adverse events: A narrative review.

Authors:  Mohammad Hassan Nezafati; Mohammad Vojdanparast; Pouya Nezafati
Journal:  ARYA Atheroscler       Date:  2015-09

6.  Burden, screening, and treatment of depressive and anxious symptoms among women referred to cardiac rehabilitation: a prospective study.

Authors:  Megan C Hurley; Heather M Arthur; Caroline Chessex; Paul Oh; Karam Turk-Adawi; Sherry L Grace
Journal:  BMC Womens Health       Date:  2017-02-07       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.